Correlation Between Jinhe Biotechnology and China International

Can any of the company-specific risk be diversified away by investing in both Jinhe Biotechnology and China International at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Jinhe Biotechnology and China International into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Jinhe Biotechnology Co and China International Capital, you can compare the effects of market volatilities on Jinhe Biotechnology and China International and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Jinhe Biotechnology with a short position of China International. Check out your portfolio center. Please also check ongoing floating volatility patterns of Jinhe Biotechnology and China International.

Diversification Opportunities for Jinhe Biotechnology and China International

0.85

Correlation Coefficient

Jinhe Biotechnology  China International

Very poor diversification

The 3 months correlation between Jinhe and China is 0.85. Overlapping area represents the amount of risk that can be diversified away by holding Jinhe Biotechnology Co and China International Capital in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on China International and Jinhe Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Jinhe Biotechnology Co are associated (or correlated) with China International. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of China International has no effect on the direction of Jinhe Biotechnology i.e., Jinhe Biotechnology and China International go up and down completely randomly.

Pair Corralation between Jinhe Biotechnology and China International

Assuming the 90 days trading horizon Jinhe Biotechnology Co is expected to generate 0.6 times more return on investment than China International. However, Jinhe Biotechnology Co is 1.68 times less risky than China International. It trades about 0.24 of its potential returns per unit of risk. China International Capital is currently generating about 0.13 per unit of risk. If you would invest  351.00  in Jinhe Biotechnology Co on September 13, 2024 and sell it today you would earn a total of  122.00  from holding Jinhe Biotechnology Co or generate 34.76% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Strong
Accuracy	100.0%
Values	Daily Returns

Jinhe Biotechnology Co  vs.  China International Capital

Jinhe Biotechnology

Risk-Adjusted Performance

18 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Jinhe Biotechnology Co are ranked lower than 18 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Jinhe Biotechnology sustained solid returns over the last few months and may actually be approaching a breakup point.

China International

Risk-Adjusted Performance

10 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in China International Capital are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, China International sustained solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Jinhe Biotechnology and China International

The main advantage of trading using opposite Jinhe Biotechnology and China International positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Jinhe Biotechnology position performs unexpectedly, China International can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in China International will offset losses from the drop in China International's long position.

The idea behind Jinhe Biotechnology Co and China International Capital pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.